LINC01197 inhibits Influenza A Virus replication by serving as a PABPC1 decoy

Yihe Wang, Ning Shi, Hansi Zhang, Jinna Luo, Hongjian Yan, Huiyan Hou, Zhenhong Guan, Lili Zhao, Ming Duan

Abstract

Influenza A viruses (IAVs) are known to impose a significant impact on both animal and human health due to its zoonotic potential. A growing body of evidence indicates that host long noncoding RNAs (lncRNAs) play crucial roles in regulating host-virus interactions during IAV infection. However, numerous lncRNAs associated with IAV infection have not been well-characterized. Here, we identified the LINC01197 as an antiviral host factor. LINC01197 was significantly upregulated after IAV infection which is controlled by NF-κB pathway. Functional analysis demonstrated that overexpression of LINC01197 inhibited IAV replication and virus production while knockdown of LINC01197 facilitated IAV replication. Mechanistically, LINC01197 directly interacted with poly(A) binding protein cytoplasmic 1 (PABPC1), which in turn sequesters and restricts its functions. This work demonstrates that LINC01197 functions as a protein decoy to suppress IAV replication, indicating a novel function of LINC01197 in controlling IAV replication.

Introduction

Influenza A Virus (IAV) remains a persistent global health threat, characterized by its ability to cross species barriers and cause widespread pandemics. The host response to IAV infection involves a complex network of signaling pathways and regulatory molecules. Among these, long noncoding RNAs (lncRNAs)—transcripts exceeding 200 nucleotides that lack protein-coding potential—have emerged as pivotal regulators of the innate immune response. Despite their importance, the functional roles of many IAV-induced lncRNAs remain poorly understood. This study characterizes LINC01197, a host lncRNA that acts as a molecular decoy to suppress IAV replication.

Results

Induction of LINC01197 via the NF-κB Pathway

Upon infection with various IAV strains (including PR8, WSN, and H3N2), human lung epithelial cells (A549) exhibit a significant, time- and dose-dependent upregulation of LINC01197. This induction is not limited to live virus; treatment with poly(I:C), a synthetic mimic of viral double-stranded RNA, also triggers LINC01197 expression, suggesting it is part of a broader innate immune response. Mechanistic studies using the NF-κB inhibitor BAY11-7082 and Chromatin Immunoprecipitation (ChIP) assays confirmed that the NF-κB signaling pathway directly regulates LINC01197 transcription by binding to its promoter region.

LINC01197 Exerts Potent Antiviral Activity

To determine the functional significance of LINC01197, researchers performed gain- and loss-of-function experiments. Overexpression of LINC01197 significantly reduced the levels of viral M1 protein and lowered viral titers (measured by TCID₅₀). Conversely, knocking down LINC01197 using siRNA enhanced viral replication, indicating that the lncRNA is a critical component of the host's defense mechanism.

Figure 1: LINC01197 is induced by IAV infection and inhibits viral replication.

Mechanism: LINC01197 as a PABPC1 Decoy

The study employed RNA pull-down assays followed by Mass Spectrometry to identify the molecular partners of LINC01197. Among 39 identified RNA-binding proteins, Poly(A) Binding Protein Cytoplasmic 1 (PABPC1) emerged as the primary functional interactor. PABPC1 is typically hijacked by IAV to facilitate the translation of viral mRNAs. LINC01197 acts as a molecular decoy, sequestering PABPC1 in the cytoplasm and preventing it from interacting with the viral NS1 protein. By disrupting this interaction, LINC01197 effectively starves the virus of the machinery required for efficient protein synthesis.

Discussion

The identification of LINC01197 as an antiviral factor adds a new layer to our understanding of host-virus interactions. By acting as a decoy for PABPC1, LINC01197 intercepts a critical host factor that the virus relies on for translation. This mechanism is particularly elegant as it is integrated into the NF-κB pathway, ensuring that the decoy is produced precisely when the cell detects a viral threat. While this study provides strong evidence in lung epithelial cell lines, future research using in vivo models will be essential to evaluate the therapeutic potential of modulating LINC01197 levels. Additionally, the discovery of 38 other potential protein partners for LINC01197 suggests that its regulatory influence may extend beyond PABPC1 sequestration.

Summary updated

Abstract

<title>Abstract</title> Influenza A viruses (IAVs) are known to impose a significant impact on both animal and human health due to its zoonotic potential. A growing body of evidence indicates that host long noncoding RNAs (lncRNAs) play crucial roles in regulating host-virus interactions during IAV infection. However, numerous lncRNAs associated with IAV infection have not been well-characterized. Here, we identified the LINC01197 as an antiviral host factor. LINC01197 was significantly upregulated after IAV infection which is controlled by NF-κB pathway. Functional analysis demonstrated that overexpression of LINC01197 inhibited IAV replication and virus production while knockdown of LINC01197 facilitated IAV replication. Mechanistically, LINC01197 directly interacted with poly(A) binding protein cytoplasmic 1 (PABPC1), which in turn sequesters and restricts its functions. This work demonstrates that LINC01197 functions as a protein decoy to suppress IAV replication, indicating a novel function of LINC01197 in controlling IAV replication.
BibTeX
@inproceedings{wang2024linc,
  author = {Yihe Wang and Ning Shi and Hansi Zhang and Jinna Luo and Hongjian Yan and Huiyan Hou and Zhenhong Guan and Lili Zhao and Ming Duan},
  title = {{LINC01197 inhibits Influenza A Virus replication by serving as a PABPC1 decoy}},
  booktitle = {Veterinary},
  year = {2024},
  doi = {10.1186/s13567-024-01379-7},
}
Figure